Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Costs and net health effects of contraceptive methods.

Sonnenberg FA, Burkman RT, Hagerty CG, Speroff L, Speroff T.

Contraception. 2004 Jun;69(6):447-59.

PMID:
15157789
2.

Long-term benefits and risks of alternative methods of fertility control in the United States.

Kawachi I, Colditz GA, Hankinson S.

Contraception. 1994 Jul;50(1):1-16.

PMID:
7924318
3.

Medical care cost savings from adolescent contraceptive use.

Trussell J, Koenig J, Stewart F, Darroch JE.

Fam Plann Perspect. 1997 Nov-Dec;29(6):248-55, 295.

4.
5.
6.

Cost-effectiveness and contraceptive effectiveness of the transdermal contraceptive patch.

Sonnenberg FA, Burkman RT, Speroff L, Westhoff C, Hagerty CG.

Am J Obstet Gynecol. 2005 Jan;192(1):1-9.

PMID:
15671994
7.

Pertussis in adolescents and adults: should we vaccinate?

Lee GM, Lebaron C, Murphy TV, Lett S, Schauer S, Lieu TA.

Pediatrics. 2005 Jun;115(6):1675-84.

PMID:
15930232
8.

The costs of contraception.

Torres A, Forrest JD.

Fam Plann Perspect. 1983 Mar-Apr;15(2):70-2.

PMID:
6671479
9.

A model for cost-effectiveness analyses of smoking cessation interventions applied to a Quit-and-Win contest for mothers of small children.

Johansson PM, Tillgren PE, Guldbrandsson KA, Lindholm LA.

Scand J Public Health. 2005;33(5):343-52.

PMID:
16265801
10.

The social costs of inadequate contraception.

Koenig JD, Strauss MJ, Henneberry J, Wilson TG.

Int J Technol Assess Health Care. 1996 Summer;12(3):487-97.

PMID:
8840668
11.

Cost-effectiveness of memantine for moderate to severe Alzheimer's disease in Sweden.

J├Ânsson L.

Am J Geriatr Pharmacother. 2005 Jun;3(2):77-86.

PMID:
16129384
12.

Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes.

Rosen AB, Hamel MB, Weinstein MC, Cutler DM, Fendrick AM, Vijan S.

Ann Intern Med. 2005 Jul 19;143(2):89-99.

PMID:
16027450
13.
14.

Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B.

Hutton DW, Tan D, So SK, Brandeau ML.

Ann Intern Med. 2007 Oct 2;147(7):460-9.

PMID:
17909207
15.

Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.

Wu JM, Siddiqui NY, Amundsen CL, Myers ER, Havrilesky LJ, Visco AG.

J Urol. 2009 May;181(5):2181-6. doi: 10.1016/j.juro.2009.01.037. Epub 2009 Mar 17.

PMID:
19296983
16.

Cost effectiveness of lopinavir/ritonavir compared with atazanavir plus ritonavir in antiretroviral-experienced patients in the US.

Simpson KN, Jones WJ, Rajagopalan R, Dietz B.

Clin Drug Investig. 2007;27(7):443-52. Erratum in: Clin Drug Investig. 2007;27(8):564.

PMID:
17563124
17.

Health economics of contraception.

Mavranezouli I.

Best Pract Res Clin Obstet Gynaecol. 2009 Apr;23(2):187-98. doi: 10.1016/j.bpobgyn.2008.11.007. Epub 2009 Jan 14.

PMID:
19147410
18.

Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia.

Cohen N, Minshall ME, Sharon-Nash L, Zakrzewska K, Valentine WJ, Palmer AJ.

Pharmacoeconomics. 2007;25(10):881-97.

PMID:
17887808
19.

Cost-effectiveness of alternative strategies for initiating and monitoring highly active antiretroviral therapy in the developing world.

Vijayaraghavan A, Efrusy MB, Mazonson PD, Ebrahim O, Sanne IM, Santas CC.

J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):91-100.

PMID:
17621241
20.

A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorder.

Armstrong EP, Malone DC, Erder MH.

Curr Med Res Opin. 2008 Apr;24(4):1115-21. doi: 10.1185/030079908X273309 . Epub 2008 Mar 7.

PMID:
18331669

Supplemental Content

Support Center